For the first time ever, the appropriations bill that funds the Food and Drug Administration includes report language focused on Duchenne muscular dystrophy and championed by PPMD advocates.
This week the House Appropriations Committee approved the Fiscal Year 2015 Department of Agriculture and FDA spending bill, clearing the way for the full House to act on…
ContinueAdded by Pat Furlong on May 30, 2014 at 11:22am — No Comments
EMA grants Conditional Approval for Ataluren
Ataluren, PTC Therapeutics’ nonsense suppression drug received Conditional Approval. This is a big moment for Duchenne, a…
Added by Pat Furlong on May 23, 2014 at 9:30am — 6 Comments
On May 20th, the House Energy and Commerce Subcommittee on Health held a hearing entitled, 21st Century Cures: The President’s Council of Advisors on Science and Technology (PCAST) Report on Drug Innovation.
The hearing was led by Chairman Joe Pitts (R-PA) and is part of the new 21st Century Cures initiative that seeks to accelerate the discovery, development and delivery of promising new treatments to patients.…
ContinueAdded by Ryan Fischer on May 22, 2014 at 3:30pm — No Comments
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service